TRV GP Ii, LLC, 10% Owner at Jounce Therapeutics, Inc. (JNCE), sold 15,000 shares at $7.25 ($109K) on 2020-11-17, disclosed to the SEC on 2020-11-19.
Open-market sale of $109k JNCE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |